FDA approves 2 Camber Spine devices

Emma Brauer -   Print  |
Listen
Text
  • Small
  • Medium
  • Large

King of Prussia, Pa.-based medical device company Camber Spine got a green light from the FDA for two of its lumbar spacer products, the SPIRA-P and SPIRA-T, according to an Aug. 3 company news release.

The 3D-printed products are indicated for posterior or transforaminal lumbar interbody fusion procedures in patients with degenerative disc disease.

The implants are the company’s first SPIRA products to enter the TLIF market, "the number one interbody market in the U.S. today," Daniel Pontecorvo, Camber Spine co-founder and CEO, said in the release.

Mr. Pontecorvo said the company is looking to expand its reach in the TLIF market with a TLIF SPIRA cage product launch next year.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Whitepapers

Featured Podcast